Y Matsuyama

630 citations
8 papers · 486 indexed · h-index 5
Topics
Breast Cancer Treatment Studies (3 papers)Breast Lesions and Carcinomas (3 papers)Estrogen and related hormone effects (2 papers)
Partner nations
JapanSwitzerlandIndia

In The Last Decade

Y Matsuyama

7 papers receiving 472 citations

Peers

Y Matsuyama
Comparison fields: 5 of 48
  • Oncology 381
  • Cancer Research 190
  • Surgery 174
  • Pulmonary and Respiratory Medicine 144
  • Epidemiology 138
Replace Hanguang Hu with:
Hanguang Hu China
Weimin Mao China
Masato Matsuyama Japan
Paul A. Toste United States
Dongfeng Cheng China
Yumi Izumisato Japan
Xavier Chopin‐Laly France
Yuta Kasagi Japan
Seiichi Fukuyama Japan
M Kajanti Finland
Y Matsuyama relative to Hanguang Hu China Hanguang Hu's profile →
Citations per field
00.5×3.3×
Hanguang Hu · 1×
Citations per year

Countries citing papers authored by Y Matsuyama

Since Specialization
Citations

This map shows the geographic impact of Y Matsuyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Matsuyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Matsuyama more than expected).

Fields of papers citing papers by Y Matsuyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Matsuyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Matsuyama. The network helps show where Y Matsuyama may publish in the future.

Co-authorship network of co-authors of Y Matsuyama

This figure shows the co-authorship network connecting the top 25 collaborators of Y Matsuyama. A scholar is included among the top collaborators of Y Matsuyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Matsuyama. Y Matsuyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 40
2 37
3 8
4 328
5
0
6
4
7
[Neoadjuvant endocrine therapy with anastrozole significantly downstaged an elderly breast cancer woman with locally-advanced breast cancer which became operable].
1
8 68

About Y Matsuyama

Y Matsuyama is a scholar working on Cancer Research, Pathology and Forensic Medicine and Dermatology, having authored 8 papers that have together received 486 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Breast Lesions and Carcinomas (3 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Oncology (381 citations), Cancer Research (190 citations) and Pulmonary and Respiratory Medicine (144 citations). Y Matsuyama has collaborated with scholars based in Japan, Switzerland and India. Frequent co-authors include Hideki Ueno, Masao Tanaka, Mitsuo Shimada, Ryuichiro Doi, T Kosuge, Akimasa Nakao, Shinichi Egawa, Junji Yamamoto, Morito Monden and Takashi Hatori. Their work appears in journals such as British Journal of Cancer, Journal of Surgical Oncology and Breast Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026